- Home
- DHIL vs BME Comparison
DHIL vs BME Comparison
Compare DHIL & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | DHIL | BME |
|---|---|---|
| Founded | 1990 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 463.8M | 547.5M |
| IPO Year | 1996 | 2005 |
Fundamental Metrics
Financial Performance| Metric | DHIL | BME |
|---|---|---|
| Price | $172.81 | $39.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.5K | ★ 35.3K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.47% | N/A |
| EPS Growth | ★ 14.37 | N/A |
| EPS | ★ 17.91 | N/A |
| Revenue | ★ $145,201,729.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.67 | ★ N/A |
| Revenue Growth | ★ 6.69 | N/A |
| 52 Week Low | $114.11 | $34.18 |
| 52 Week High | $173.70 | $42.74 |
Technical Indicators
Market Signals| Indicator | DHIL | BME |
|---|---|---|
| Relative Strength Index (RSI) | 65.08 | 26.59 |
| Support Level | $170.59 | $39.81 |
| Resistance Level | N/A | $40.70 |
| Average True Range (ATR) | 0.81 | 0.61 |
| MACD | -0.09 | -0.25 |
| Stochastic Oscillator | 74.52 | 9.81 |
Price Performance
Historical ComparisonAbout DHIL Diamond Hill Investment Group Inc.
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.